Your browser doesn't support javascript.
loading
The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
Ramirez Alvarez, Carlos; Kee, Carmon; Sharma, Ashwini Kumar; Thomas, Leonie; Schmidt, Florian I; Stanifer, Megan L; Boulant, Steeve; Herrmann, Carl.
Affiliation
  • Ramirez Alvarez C; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Kee C; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
  • Sharma AK; Research Group "Cellular Polarity and Viral Infection", German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Thomas L; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Schmidt FI; Health Data Science Unit, Medical Faculty Heidelberg and BioQuant, Heidelberg, Germany.
  • Stanifer ML; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.
  • Boulant S; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
  • Herrmann C; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
PLoS Pathog ; 17(6): e1009687, 2021 06.
Article in En | MEDLINE | ID: mdl-34181691

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Virus Internalization / SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS Pathog Year: 2021 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Virus Internalization / SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS Pathog Year: 2021 Type: Article Affiliation country: Germany